Hospital Pharmacy - May 2017 - 340

340
unknown, 11.1% clinical staff pharmacist in a critical care
setting, 11.1% academic positions, and 2.2% clinical staff
pharmacist in a non-ICU setting. This aligns with our findings
for the same academic year and underscores the potential
tightening in the market since this study. This study also noted
that CC PGY2 residents had some of the lowest confidence
and exposure in administration; this could help to explain
some of the discrepancy in perceptions between the 2 groups
and could offer an opportunity to realign with increased focus
on administrative experiences within CC PGY2 training.
Limitations of this survey were the inability to determine
the response rate for the DOP survey and the low overall
number of responses. However, the response rate of nearly
60% of CC RPDs is considerable, and the results likely
describe the opinion of the majority of the programs.

Conclusion
Despite a perception of the lack of critical care pharmacy job
opportunities, a survey of DOPs and CC RPDs describes a
critical care pharmacy job market with availability, relatively
rapid hiring patterns, and administrative plans for expansion
of position availability and more opportunity for the care of
critically ill patients. Opportunities for critical care trained
pharmacists appear to be prevalent; however, the scope of the
critical care pharmacy practice may need further analysis.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.

References
1. Health Forum. American Hospital Association hospital statistics, 2015 (2014 survey data). Chicago, IL: American Hospital
Association; 2015.
2. Dasta JF, Segal R, Cunningham A. National survey of
critical-care pharmaceutical services. Am J Hosp Pharm.
1989;46:2308-2312.
3. MacLaren R, Devlin JW, Martin SJ, et al. Critical care pharmacy services in United States hospitals. Ann Pharmacother.
2006;40:612-618.

Hospital Pharmacy 52(5)
4. Preslaski CR, Lat I, MacLaren R, et al. Pharmacist contributions as members of the multidisciplinary ICU team. Chest.
2013;144:1687-1695.
5. Erstad BL, Haas CE, O'Keeffe T, et al. Interdisciplinary
patient care in the intensive care unit: focus on the pharmacist.
Pharmacotherapy. 2011;31:128-137.
6. MacLaren R, McQueen RB, Campbell J. Clinical and financial impact of pharmacy services in the intensive care unit:
pharmacist and prescriber perceptions. Pharmacotherapy.
2013;33:401-410.
7. MacLaren R, Bond CA, Martin SJ, et al. Clinical and economic
outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36:31843189.
8. MacLaren R, Bond CA. Effects of pharmacist participation
in intensive care units on clinical and economic outcomes of
critically ill patients with thromboembolic or infarction-related
events. Pharmacotherapy. 2009;29:761-768.
9. Haupt MT, Bekes CE, Brilli RJ, et al. Guidelines on critical
care services and personnel: recommendations based on a system of categorization of three levels of care. Crit Care Med.
2003;31(11):2677-2683.
10. American Association of Colleges of Pharmacy Graduating
Student Survey 2015 national summary report. www.aacp.org.
Accessed March 11, 2016.
11. American Association of Colleges of Pharmacy Graduating
Student Survey 2010 national summary report. www.aacp.org.
Accessed March 11, 2016.
12. National Matching Services Inc, ASHP Resident Matching
Program. Summary of programs and positions offered and
filled for the 2015 Match. https://www.natmatch.com/ashprmp/stats/2015summpos.html. Accessed March 11, 2016.
13. National Matching Services Inc, ASHP Resident Matching
Program. Summary of programs and positions offered and
filled for the 2011 Match. https://www.natmatch.com/ashprmp/stats/2011summpos.html. Accessed March 11, 2016.
14. Zellmer WA, ed. Pharmacy forecast 2016-2020: strategic
planning advice for pharmacy departments in hospitals and
health systems. Bethesda, MD: ASHP Research and Education
Foundation; 2015. www.ashpfoundation.org/pharmacyforecast. Accessed March 11, 2016.
15. Pharmacy Workforce Center. Aggregate demand index. About
ADI. https://pharmacymanpower.com/index.php. Accessed
March 11, 2016.
16. Buckley MS, MacLaren R, Frazee EN, et al. Surveying residents of postgraduate year 2 critical care pharmacy residencies about their level of preparedness to practice. Curr Pharm
Teach Learn. 2014;6:76-84.


http://www.aacp.org http://www.aacp.org https://www.natmatch.com/ashprmp/stats/2015summpos.html https://www.natmatch.com/ashprmp/stats/2015summpos.html https://www.natmatch.com/ashprmp/stats/2011summpos.html https://www.natmatch.com/ashprmp/stats/2011summpos.html http://www.ashpfoundation.org/pharmacyforecast http://www.ashpfoundation.org/pharmacyforecast https://www.pharmacymanpower.com/index.php

Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017

Editorial, For Sale: FDA Priority Review Vouchers
Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Pharmacists’ Knowledge of the Cost of Laboratory Testing
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 317
Hospital Pharmacy - May 2017 - 318
Hospital Pharmacy - May 2017 - 319
Hospital Pharmacy - May 2017 - 320
Hospital Pharmacy - May 2017 - 321
Hospital Pharmacy - May 2017 - 322
Hospital Pharmacy - May 2017 - 323
Hospital Pharmacy - May 2017 - Editorial, For Sale: FDA Priority Review Vouchers
Hospital Pharmacy - May 2017 - 325
Hospital Pharmacy - May 2017 - Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Hospital Pharmacy - May 2017 - Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
Hospital Pharmacy - May 2017 - 328
Hospital Pharmacy - May 2017 - 329
Hospital Pharmacy - May 2017 - ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Hospital Pharmacy - May 2017 - 331
Hospital Pharmacy - May 2017 - 332
Hospital Pharmacy - May 2017 - 333
Hospital Pharmacy - May 2017 - Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Hospital Pharmacy - May 2017 - 335
Hospital Pharmacy - May 2017 - 336
Hospital Pharmacy - May 2017 - 337
Hospital Pharmacy - May 2017 - 338
Hospital Pharmacy - May 2017 - 339
Hospital Pharmacy - May 2017 - 340
Hospital Pharmacy - May 2017 - Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Hospital Pharmacy - May 2017 - 342
Hospital Pharmacy - May 2017 - 343
Hospital Pharmacy - May 2017 - 344
Hospital Pharmacy - May 2017 - 345
Hospital Pharmacy - May 2017 - 346
Hospital Pharmacy - May 2017 - 347
Hospital Pharmacy - May 2017 - Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Hospital Pharmacy - May 2017 - 349
Hospital Pharmacy - May 2017 - 350
Hospital Pharmacy - May 2017 - 351
Hospital Pharmacy - May 2017 - 352
Hospital Pharmacy - May 2017 - Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Hospital Pharmacy - May 2017 - 354
Hospital Pharmacy - May 2017 - 355
Hospital Pharmacy - May 2017 - 356
Hospital Pharmacy - May 2017 - Pharmacists’ Knowledge of the Cost of Laboratory Testing
Hospital Pharmacy - May 2017 - 358
Hospital Pharmacy - May 2017 - 359
Hospital Pharmacy - May 2017 - 360
Hospital Pharmacy - May 2017 - Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Hospital Pharmacy - May 2017 - 362
Hospital Pharmacy - May 2017 - 363
Hospital Pharmacy - May 2017 - 364
Hospital Pharmacy - May 2017 - 365
Hospital Pharmacy - May 2017 - 366
Hospital Pharmacy - May 2017 - Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Hospital Pharmacy - May 2017 - 368
Hospital Pharmacy - May 2017 - 369
Hospital Pharmacy - May 2017 - 370
Hospital Pharmacy - May 2017 - 371
Hospital Pharmacy - May 2017 - 372
Hospital Pharmacy - May 2017 - 373
Hospital Pharmacy - May 2017 - Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 375
Hospital Pharmacy - May 2017 - 376
Hospital Pharmacy - May 2017 - 377
Hospital Pharmacy - May 2017 - 378
Hospital Pharmacy - May 2017 - 379
Hospital Pharmacy - May 2017 - 380
Hospital Pharmacy - May 2017 - 381
Hospital Pharmacy - May 2017 - 382
Hospital Pharmacy - May 2017 - 383
Hospital Pharmacy - May 2017 - 384
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
http://www.nxtbook.com/nxtbooks/sage/fai_201909
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
http://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
http://www.nxtbook.com/nxtbooks/sage/tec_20180810
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
http://www.nxtbook.com/nxtbooks/sage/fai_201807
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
http://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
http://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
http://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
http://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
http://www.nxtbook.com/nxtbooks/sage/fai_201706
http://www.nxtbook.com/nxtbooks/sage/fai_201607
http://www.nxtbookMEDIA.com